Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures.

ABSTRACT:

Background

The real-world impact of breathing zone air purification and coronavirus disease 2019 (COVID-19) mitigation measures on healthcare-associated infections is not well documented. Engineering solutions to treat airborne transmission of disease may yield results in controlled test chambers or single rooms, but have not been reported on hospital-wide applications, and the impact of COVID-19 mitigation measures on healthcare-associated infection rates is unknown.

Aim

To determine the impact of hospital-wide bioaerosol treatment and COVID-19 mitigation measures on clinical outcomes.

Methods

The impact of the step-wise addition of air disinfection technology and COVID-19 mitigation measures to standard multi-modal infection control on particle counts, viral and bac

SUBMITTER: Ereth MH 

PROVIDER: S-EPMC8295046 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature